Floatz logo

Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer

Metastatic Hepatocellular Carcinoma

M.D. Anderson Cancer Centermonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

520 Active assets in the Metastatic Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Adefovir
Bukwang Pharmaceutical
Phase 4BBB
Huaier Granule
Tongji Hospital
Phase 4BBB
Sorafenib
Bayer
Phase 4BBB
Carboplatin
AstraZeneca
Phase 4BB
Theprubicin
RWTH Aachen University
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer is also rated in:

esophageal cancerDormant
CC
Indicative ·
43 / 100
View asset →
head and neck carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
Metastatic HPV Related Solid TumorsDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →